News

Treating ALS in a Dish? Models Point to Drug Candidate for Sporadic Disease

Since sporadic neurodegenerative diseases have unknown and potentially multiple etiologies, cells derived from a single patient may not be the best option for screening drugs to treat all. Enter case clustering. As reported in the August 20 Nature Medicine, researchers led by Hideyuki Okano at Keio University School of Medicine in Tokyo have characterized the […]

Read more »